Description
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HER2/neu (869-877) is a peptide fragment of the HER2/neu receptor, also known as CD340, EGFR2, or erbB2. This receptor exhibits anti-apoptotic activity and is associated with breast and other cancers.
| Purity | ≥95% |
|---|---|
| Formula | C49H75N9O20 |
| Formula Wt. | 1110.19 |
| Synonym | ErbB2, EGFR2 |
| Solubility | Soluble in water. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Mitri Z, Constantine T, O'Regan R. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy. Chemother Res Pract. 2012;2012:743193. PMID: 23320171.
Roy V, Perez EA. Beyond trastuzumab: small molecule tyrosine kinase inhibitors in HER-2-positive breast cancer. Oncologist. 2009 Nov;14(11):1061-9. PMID: 19887469.
Synthetic catechol; ER agonist, microtubule pol...
PKG inhibitor.
BHA derivative; potential Ca2+ ATPase inhibitor...
mTOR activator.
Mycotoxin, metabolite of aflatoxin B1 produced ...
Endogenous peptide, involved in water/Na+ homeo...
Synthesis impurity
Endogenous neuropeptide hormone, lowers extrace...
Cyclic depsipeptide is a secondary metabolite i...
Toxin produced by Aspergillus.
Cyclosporin metabolite; weak calmodulin inhibit...
p110β PI3K inhibitor.
Endogenous steroid hormone involved in stress s...
Iron chelator.
Cysteine-ITC conjugate.
Piperazine; FIASMA, D2 antagonist, hERG K+ chan...
Thalidomide derivative; cereblon and TNF-α inh...
Islet β cell proliferation stimulator.
Cysteine-ITC conjugate, antioxidant; HDAC inhib...
p38 MAPK inhibitor.